Delivery Order SPE2DB22D3016-SPE2DB25FBEN4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,815.02 to supply Humalog 100 Unit/mL KwikPen 3 mL insulin pens. This is a firm fixed-price delivery order with no set-aside designation, completed on August 1, 2025, and fulfills pharmaceutical supply requirements for federal medical procurement. The award leverages AmerisourceBergen's established capacity as a critical pharmaceutical distributor within the federal supply chain, particularly for...
- The Defense Logistics Agency awarded a $1,069.96 delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/ML KwikPen 3ML insulin pens, with an ultimate completion date of July 22, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Humalog 100 Unit/mL KwikPen 3mL insulin pens at a firm fixed price of $2,082.52, with an ultimate completion date of July 21, 2025. This is a non-set-aside, competitively awarded contract performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract (SPE2DB24FTGQ9) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply Humalog 100 unit/mL KwikPen 3mL insulin pens. The delivery order is valued at $1,024.32 and has a performance period through March 18, 2024. This delivery order is placed under a larger indefinite delivery contract (SPE2DB22D1103) awarded solely to AmerisourceBergen Drug Corp, with a potential value...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,227.19 to supply Humalog 100 Unit/mL KwikPen 3mL insulin pens. This contract, which was not set-aside for small business, was executed on August 14, 2025, with an ultimate completion date of August 15, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. The delivery order...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens, valued at $3,097.52. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the...
- This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply Humalog 100 unit/mL KwikPen 3mL insulin pens. The contract has a ceiling value of $1,024.32 and a period of performance through April 4, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens, valued at $6,578.04. This competitively awarded, firm fixed-price delivery order is set to be completed by August 14, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a discrete pharmaceutical procurement under AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, valued at $20,724.74. This non-set-aside, firm fixed-price delivery order is scheduled for completion by August 5, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The contract represents a continuation of pharmaceutical procurement through DLA's medical supply chain to support federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, valued at $18,663.84 under a firm fixed-price contract type. This non-set-aside award represents a critical pharmaceutical procurement to support federal healthcare operations, with an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBEN4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Humalog 100 Unit/mL KwikPen 3mL insulin pens, with a ceiling value of $1,048.07. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is executed under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Through this contract vehicle, AmerisourceBergen supplies critical pharmaceutical commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/11/25 |